The March issue of Pharmaceutical Executive delves into seasonal-type changes that have occurred for market sectors or are guiding new practices for various functions. Highlighting the coverage is the latest life sciences business pulse check from Peter Young, CEO of Young and Partners. Young also likes to examine the future outlook for pharma and biotech companies and the key implications for senior leaders.